These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37810598)

  • 1. Manic episode following psilocybin use in a man with bipolar II disorder: a case report.
    Halim HJ; Burk BG; Fargason RE; Birur B
    Front Psychiatry; 2023; 14():1221131. PubMed ID: 37810598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.
    DellaCrosse M; Pleet M; Morton E; Ashtari A; Sakai K; Woolley J; Michalak E
    PLoS One; 2022; 17(12):e0279073. PubMed ID: 36516137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms.
    Lugo-Radillo A; Cortes-Lopez JL
    J Psychoactive Drugs; 2021; 53(2):146-148. PubMed ID: 33225874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.
    Morton E; Sakai K; Ashtari A; Pleet M; Michalak EE; Woolley J
    J Psychopharmacol; 2023 Jan; 37(1):49-60. PubMed ID: 36515370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical particularism of bipolar disorder: unipolar mania. About a patient's study in Tunesia].
    Dakhlaoui O; Essafi I; Haffani F
    Encephale; 2008 Sep; 34(4):337-42. PubMed ID: 18922234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroconvulsive therapy for manic state with mixed and psychotic features in a teenager with bipolar disorder and comorbid episodic obsessive-compulsive disorder: a case report.
    Rask O; Suneson K; Holmström E; Bäckström B; Johansson BA
    J Med Case Rep; 2017 Dec; 11(1):345. PubMed ID: 29228982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report.
    Hendin HM; Penn AD
    Bipolar Disord; 2021 Nov; 23(7):733-735. PubMed ID: 33934465
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DARK Classics in Chemical Neuroscience: Psilocybin.
    Geiger HA; Wurst MG; Daniels RN
    ACS Chem Neurosci; 2018 Oct; 9(10):2438-2447. PubMed ID: 29956917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Therapeutic Potential of Psilocybin.
    Lowe H; Toyang N; Steele B; Valentine H; Grant J; Ali A; Ngwa W; Gordon L
    Molecules; 2021 May; 26(10):. PubMed ID: 34063505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.
    Moreno FA; Wiegand CB; Taitano EK; Delgado PL
    J Clin Psychiatry; 2006 Nov; 67(11):1735-40. PubMed ID: 17196053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of psychedelics in psychiatry, a systematic review of the literature].
    Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A
    Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psilocybin and Obsessive Compulsive Disorder.
    Wilcox JA
    J Psychoactive Drugs; 2014; 46(5):393-5. PubMed ID: 25364991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with psilocybin: applications for patients with psychiatric disorders].
    Breeksema JJ; Koolen MHB; Somers M; Schoevers RA
    Ned Tijdschr Geneeskd; 2021 Jan; 165():. PubMed ID: 33560605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of and factors associated with manic episodes and bipolar disorder in the decade following depression onset in Germany.
    Jacob L; Bohlken J; Kostev K
    J Affect Disord; 2020 Apr; 266():534-539. PubMed ID: 32056923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hallucinogenic mushrooms.
    Schwartz RH; Smith DE
    Clin Pediatr (Phila); 1988 Feb; 27(2):70-3. PubMed ID: 3338231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical potential of psilocybin as a treatment for mental health conditions.
    Daniel J; Haberman M
    Ment Health Clin; 2017 Jan; 7(1):24-28. PubMed ID: 29955494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.
    Honyiglo E; Franchi A; Cartiser N; Bottinelli C; Advenier AS; Bévalot F; Fanton L
    J Forensic Sci; 2019 Jul; 64(4):1266-1270. PubMed ID: 30548541
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.